Ann: Appendix 4E and Annual Report to Shareholders, page-19

Simple.
Some large SDX shareholders had done their dough and saw a way of getting it back.

I think its flawed.
How hard would it be to sell the first proven blood test for Ovarian/Breast/Lung cancer?
There would be a myriad of very large companies lining up to market the test. All of which would have the global muscle required to make it happen.
SDX management are shite and we should be rid of them.
Have a look at their spending.....out of control.
I sold some BD1, about half my holding the other day, I'm not happy with the dilution and then when I looked at the cash position I nearly fell off my chair!